Navigation Links
URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards
Date:11/10/2008

onal events throughout the year. Presentations will showcase working best practices in two categories: consumer decision-making and consumer health improvement.

All finalists are invited to attend a black tie dinner event during the conference, at which time they will discover how they will be distinguished as award winners. Gold, Silver and Bronze awards, as well as those receiving Honorable Mention awards, in each of the four organization categories, will be named at the dinner. Platinum award winners will also be announced in the two topic categories.

Finalists in URAC's Best Practices Awards competition are:

-- Blue Cross and Blue Shield of Oklahoma, "Office-Based

Cardiovascular Stress Testing"

-- Blue Cross Blue Shield of Illinois, "The Positive Impact of Written

Asthma Action Plans"

-- CareFirst BlueCross BlueShield, "Cultural Excellence Training"

-- Centene Corporation, "CONNECTIONS PLUS"

-- Ceridian, "Health & Wellness Outreach and Engagement"

-- Children's Mercy Family Health Partners, "CMFHP Disease

Management Program"

-- CIGNA HealthCare, "Colorectal Cancer Screening Program"

-- Companion Benefit Alternatives, "Essential Solutions for Depression

Management"

-- Comprehensive NeuroScience, Eli Lilly and Company, and The State of

Arkansas Department of Human Services, "Arkansas Diabetes Disease

Management Program Phase 3"

-- CVS Caremark, "Drug Therapy Management"

-- Delaware Physicians Care, Incorporated, "DPCI Diabetes Text

Messaging Pilot Project"

-- Eliza Corporation and Kaiser Permanente of the Mid-Atlantic States,

"Eliza Corporation"

-- Great Moves! and Children's Hospital Boston, "Great Moves!

Pediatric Weight Management Center"

-- HealthPartners, "Improving Employee Health through Behavior

Change"

-- New Directions Behavioral H
'/>"/>

SOURCE URAC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...ake steps to eliminate triggers, experts advise , ...y,re not Scrooges, but people with allergies and a...aditions and need to take special steps to prevent...College of Allergy, Asthma and Immunology (ACAAI)....hoose to decorate with artificial plants, but both...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...Is to Educate Patients and Others about Opportunit...ctal Cancer, ANNAPOLIS, Md., Sept. 4 The Nationa...g and Care announced the appointment of,Randall H....logy Associates, LLC states, "We are pleased to ha...
... --- There,s no magic bullet for wiping out malari...hod that effectively delays the evolution of drug ...lorida researcher says. , David Smith, associate ... current artemisinin-based malaria drugs combined ...
...SAFC Pharma(TM), a focus,area within SAFC(R) ( htt...drich(R) Group (Nasdaq: SIAL ), today officially ...to its Madison (Wisconsin) facility,designed to si...chase of 15 acres of green space in Verona (Wiscon...
...ed Organic and Fair Trade-Certified Drink Featured... Products, NEWTOWN, Pa., Sept. 3 Steaz, the prem...-Certified beverages, has been included on,Women,s...gnizing Steaz, Women,s Health notes consumers can ...
...al, levels triple risk of aggressive disease , ...whose serum calcium levels fall within the high en...to develop fatal prostate cancer, a new report sho...ading too much into the study, given the relativel...
... In July, Christine Demers and Areeba Sadiq ...e and the research coordinator at The Feinstein In...ves but they were going West in search of the seru...q set off for a family reunion in Arkansas. The nu...
Other Medicine News:Health News:National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry: 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 3Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 2Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 3Health News:Steaz Named to Women's Health List of 125 Best Packaged Foods for Women 2Health News:Study Links Serum Calcium, Prostate Cancer Death 2Health News:Study Links Serum Calcium, Prostate Cancer Death 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 2Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 4Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 5
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 1Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 2Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 3Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 4Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 5Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 6Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 7Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 8Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 9Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 10Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 11Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 12Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 13MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 6597 1MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 6597 2eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 1eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 2
...N, South Korea, Jan. 12 Jennerex,Inc. (San Franci... partner,Green Cross Corp., today announced treatm...y liver cancer clinical trial using its targeted a...s were reported, and enrollment of,patients onto t...volves treatment of patients with advanced, primar...
...Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a ... and development of drugs for the treatment of hum...unced that it has initiated a proof-of-concept stu...candidate for the treatment of HCV under an Invest... Food and Drug Administration (FDA). The study is ...
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 2Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 3Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 4
Creatine Kinase (CK-NAC)
Alanine Aminotransferase (ALT) GPT
Alkaline Phosphatase (ALP) (DIMENSION)
...ost other EMR,systems require you to,change th...c patient charting,solution designed to fit into...round,five specific criteria to,enhance overal...oPad allows you to see,more patients in the same...
Medicine Products: